Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta …

M Huhn, A Nikolakopoulou, J Schneider-Thoma… - The Lancet, 2019 - thelancet.com
Background Schizophrenia is one of the most common, burdensome, and costly psychiatric
disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is …

Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017

C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …

Biological insights from 108 schizophrenia-associated genetic loci

C Pantelis, GN Papadimitriou, S Papiol… - Nature, 2014 - nature.com
Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of
alleles, including common alleles of small effect that might be detected by genome-wide …

[HTML][HTML] Biological insights from 108 schizophrenia-associated genetic loci

S Ripke, BM Neale, A Corvin, JTR Walters, KH Farh… - Nature, 2014 - ncbi.nlm.nih.gov
Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of
alleles, including common alleles of small effect that might be detected by genome-wide …

[PDF][PDF] Obesity: definition, comorbidities, causes, and burden

CM Apovian - Am J Manag Care, 2016 - ajmc.s3.amazonaws.com
Body mass index of 30 kg/m2 or higher is used to identify individuals with obesity. In the last
3 decades, the worldwide prevalence of obesity has increased 27.5% for adults and 47.1 …

Pharmacological management of obesity: an endocrine Society clinical practice guideline

CM Apovian, LJ Aronne, DH Bessesen… - The Journal of …, 2015 - academic.oup.com
Objective: To formulate clinical practice guidelines for the pharmacological management of
obesity. Participants: An Endocrine Society-appointed Task Force of experts, a …

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey… - The Lancet, 2013 - thelancet.com
Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …

Master protocols to study multiple therapies, multiple diseases, or both

J Woodcock, LM LaVange - New England Journal of Medicine, 2017 - Mass Medical Soc
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

[HTML][HTML] Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

M De Hert, CU Correll, J Bobes… - World …, 2011 - ncbi.nlm.nih.gov
The lifespan of people with severe mental illness (SMI) is shorter compared to the general
population. This excess mortality is mainly due to physical illness. We report prevalence …

Rethinking schizophrenia

TR Insel - Nature, 2010 - nature.com
How will we view schizophrenia in 2030? Schizophrenia today is a chronic, frequently
disabling mental disorder that affects about one per cent of the world's population. After a …